Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia. | Front Oncol | 2021 | 35087759 | PubTator, text mining | PubMed |
| The Primary Immunodeficiency Database in Japan. | Front Immunol | 2021 | 35082792 | PubTator, text mining | PubMed |
| Magnetic resonance neuroimaging promotes the preservation of pelvic autonomic nerves in laparoscopic total mesorectal excision: a comparative study. | Ann Transl Med | 2021 | 35071450 | PubTator, text mining | PubMed |
| Insights on Cancer Cell Inhibition, Subcellular Activities, and Kinase Profile of Phenylacetamides Pending 1H-Imidazol-5-One Variants. | Front Pharmacol | 2021 | 35069208 | PubTator, text mining | PubMed |
| Case Report: Autoimmune Lymphoproliferative Syndrome vs. Chronic Active Epstein-Barr Virus Infection in Children: A Diagnostic Challenge. | Front Pediatr | 2021 | 35036396 | PubTator, text mining | PubMed |
| Dengue-Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review. | Cureus | 2021 | 35003998 | PubTator, text mining | PubMed |
| Analyses of circRNA and mRNA Profiles in Vogt-Koyanagi-Harada Disease. | Front Immunol | 2021 | 35003060 | PubTator, text mining | PubMed |
| Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib. | Onco Targets Ther | 2021 | 35002256 | PubTator, text mining | PubMed |
| Recent Research Progress of Chiral Small Molecular Antitumor-Targeted Drugs Approved by the FDA From 2011 to 2019. | Front Oncol | 2021 | 34976824 | PubTator, text mining | PubMed |
| Comprehensive Analysis to Identify MAGEA3 Expression Correlated With Immune Infiltrates and Lymph Node Metastasis in Gastric Cancer. | Front Oncol | 2021 | 34970496 | PubTator, text mining | PubMed |
| Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features. | Front Oncol | 2021 | 34956898 | PubTator, text mining | PubMed |
| Ionic Regulation of T-Cell Function and Anti-Tumour Immunity. | Int J Mol Sci | 2021 | 34948472 | PubTator, text mining | PubMed |
| Hemophagocytic Lymphohistiocytosis as Initial Presentation of Malignancy in Pediatric Patients: Rare but Not to Be Ignored. | Children (Basel) | 2021 | 34943279 | PubTator, text mining | PubMed |
| An overview of kinase downregulators and recent advances in discovery approaches. | Signal Transduct Target Ther | 2021 | 34924565 | PubTator, text mining | PubMed |
| Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells. | Clin Transl Med | 2021 | 34919342 | PubTator, text mining | PubMed |
| Dual Inhibition of IL-2-Inducible T-Cell Kinase (ITK) and Tropomyosin Receptor Kinase A (TRKA) as Potential Treatment for Atopic Dermatitis and Other Inflammatory and Autoimmune Diseases. | ACS Med Chem Lett | 2021 | 34917248 | PubTator, text mining | PubMed |
| Targeting PI3K/Akt signal transduction for cancer therapy. | Signal Transduct Target Ther | 2021 | 34916492 | PubTator, text mining | PubMed |
| Use of a Network-Based Method to Identify Latent Genes Associated with Hearing Loss in Children. | Front Cell Dev Biol | 2021 | 34912812 | PubTator, text mining | PubMed |
| Transcriptomics of single dose and repeated carbon black and ozone inhalation co-exposure highlight progressive pulmonary mitochondrial dysfunction. | Part Fibre Toxicol | 2021 | 34911549 | PubTator, text mining | PubMed |
| A Network-Centric Framework for the Evaluation of Mutual Exclusivity Tests on Cancer Drivers. | Front Genet | 2021 | 34899838 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=39